<DOC>
	<DOCNO>NCT01588275</DOCNO>
	<brief_summary>The purpose study compare cost-effectiveness effectiveness mandibular reposition appliance ( MRA ) versus Continuous positive airway pressure ( CPAP ) therapy patient moderate Obstructive Sleep Apnea Syndrome ( OSAS ) .</brief_summary>
	<brief_title>MRA Therapy Versus CPAP Therapy Moderate OSAS</brief_title>
	<detailed_description>Study design : In randomize parallel control study 86 patient randomly assign either MRA therapy CPAP therapy . Group A receive MRA . Group B receive CPAP . The total duration study 12 month . Measurements do baseline , 3 , 6 12 month . Intervention : Group A treat bibloc MRA ( Somnodent ) . The mandible set 70 % patient 's maximum advancement adjust convenience patient . Titration continue symptom abate advancement cause discomfort . Group B treat CPAP . Proper CPAP-pressure set patient separately . Patients fit comfortable CPAP mask titration CPAP-pressure . For CPAP-titration , patient instruct adopt typical sleeping habit .</detailed_description>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Individuals subject polysomnography diagnose moderate ( AHI 1530 ) OSAS ; Aged â‰¥ 18 year ; Medical psychological criterion : Patients previously treat OSAS ( e.g . CPAP , MRA ) ; Morphologic abnormalities upper airway ( e.g. , compromise nasal passage , enlarge tonsil adenoid , upper airway softtissue craniofacial abnormality ) ; Reported document unstable endocrine dysfunction ( hypothyroidism , acromegaly , pituitary adenoma ) ; Reported document severe cardiovascular pulmonary comorbidity Clinically concurrent cardiovascular disease ( coronary artery disease , heart failure , cardiac arrhythmia ) CVA within 6 month prior randomisation Daytime respiratory insufficiency Severe Chronic Obstructive Pulmonary Disease ( COPD ) ( GOLD 3 4 ; FEV1 / FVC &lt; 70 % FEV1 &lt; 50 % ) ; Other disease may impact evaluation result study accord investigator 's judgement . Reported documented psychological condition preclude informed consent ( e.g. , mental retardation , depression schizophrenia ) ; Whether patient unstable endocrine dysfunction , severe cardiovascular pulmonary comorbidity psychological condition preclude informed consent , assess evaluate patient 's medical record . Dental exclusion criterion : Extensive periodontal disease tooth decay ; Active temporomandibular joint disease ( include severe bruxism ) ; Restrictions mouth opening ( &lt; 25mm ) advancement mandible &lt; 5mm ) ; Partial complete edentulism ( less eight teeth upper low jaw ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>cost-effectiveness</keyword>
	<keyword>effectiveness</keyword>
	<keyword>treatment</keyword>
	<keyword>CPAP</keyword>
	<keyword>MRA</keyword>
</DOC>